Aroma

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aroma

Property Description
Active Ingredient Ketoconazole
Form Medicated Shampoo (Topical Suspension)
Pharmacological Class Azole Antifungal
General Purpose To combat superficial fungal proliferation
Origin Synthetic

What Type of Medicine is Aroma (Ketoconazole)?

Aroma is a specific synthetic pharmaceutical preparation containing the active compound Ketoconazole, which is classified as an Azole antifungal agent. This medication is supplied as a medicated shampoo, representing a liquid suspension intended for topical administration to the external skin or scalp. Unlike many general-purpose cleansers, the shampoo base is engineered to ensure the active component concentrates precisely where the fungal activity is occurring.

Ketoconazole is an imidazole derivative that functions as a single active ingredient product. Ketoconazole belongs to a class of antimycotics recognized for its efficacy against cutaneous fungal pathogens.


The General Purpose of Ketoconazole and its Antifungal Class

The fundamental general purpose of Ketoconazole is to act as a potent antimycotic agent, helping to control the proliferation of various types of fungi and yeasts on the body's surface. This is achieved through its primary mechanism: the drug interferes with the production of ergosterol, a crucial lipid required to maintain the structural integrity of fungal cell membranes.

By targeting this specific biochemical pathway, the compound compromises the stability of the fungal cells, leading to a therapeutic effect. The action of Azoles, including Ketoconazole, is essential for controlling superficial fungal manifestations. This medicine helps control the growth of the underlying organisms responsible for certain external skin conditions. This unique fungistatic and fungicidal action defines the medication's core benefit: the targeted interruption of fungal growth and survival.

Regulatory References

  1. NIH: DailyMed (Ketoconazole Shampoo)

What side effects are possible with Aroma?

Possible Side Effects and Safety Information

The official safety profile for topical Ketoconazole medicated shampoo is largely characterized by localized adverse reactions due to its minimal systemic absorption. Regulatory authorities classify these effects to communicate their estimated frequency and the physiological system affected.


Frequency-Classified Adverse Reactions

The most commonly documented effects are confined to the application site. Regulatory classification defines the likelihood of appearance:

  • Common: Application site erythema (redness) and application site pruritus (itching).
  • Uncommon: Folliculitis, hair texture change, increased lacrimation (watery eyes), and localized reactions such as burning sensation, irritation, dry skin, or rash. Hypersensitivity reactions are also listed as uncommon.
  • Rare: Conditions such as alopecia (hair loss), acne, and contact dermatitis are documented in the rare frequency category.

System-Organ Class and Serious Reactions

Adverse reactions are formally grouped into System-Organ Classes, predominantly affecting Skin and Subcutaneous Tissue Disorders and General Disorders and Administration Site Conditions. The safety summary also includes Immune System Disorders.

While uncommon, severe hypersensitivity reactions are documented and include rare reports of urticaria (hives) and angioedema (swelling beneath the skin). These serious allergic responses are noted in the safety profile as they require attention.


Population-Specific Safety and Restrictions

Official labels include statements regarding use during pregnancy and lactation, advising caution and adherence to risk-benefit assessment, acknowledging the minimal systemic absorption of the topical formulation. Use is formally contraindicated in individuals with a known hypersensitivity to Ketoconazole or any other component (excipient) in the shampoo formulation.

Overdose and Emergency Response

Aroma Overdose and When to Seek Help

The official regulatory profile for Aroma (Ketoconazole Medicated Shampoo) addresses potential overdose primarily through the risk of accidental oral ingestion, as overdose via routine topical application is not anticipated due to negligible systemic absorption.

Mandatory Emergency Actions

In the event of accidental oral ingestion, it is mandatory to seek immediate medical attention or contact a Poison Control Center right away. Additionally, immediate emergency medical help must be sought if signs of a severe hypersensitivity reaction (such as swelling of the mouth/throat, difficulty breathing, or fainting) occur during use.

Official Management Statements

  • Management procedures must utilize supportive and symptomatic measures.
  • Induced emesis (vomiting) and gastric lavage must not be performed.
  • This prohibition is explicitly mandated to prevent the severe, life-threatening risk of aspiration into the lungs, a complication associated with the liquid formulation.
  • No specific antidote is known for this product's overdose.

The regulatory documents define the required emergency response and procedural constraints necessary for safety. There are no population-specific considerations or extended monitoring requirements detailed in the official overdose section.

Therapeutic Uses of Aroma

Quick Facts: Aroma Therapeutic Domains

  • Supportive Use: May serve as a complementary approach to standard care.
  • Emotional State: May help promote feelings of relaxation and well-being.
  • Symptom Relief: May be used to assist in the management of stress, anxiety, and sleep issues.

Aroma (referring to the practice of aromatherapy) is a complementary health strategy that may be used to support overall wellness and assist with symptom management as part of an integrated regimen. The primary uses are focused on addressing aspects of psychological and physical discomfort.

Aroma may help manage symptoms associated with temporary or situational anxiety and stress. It is also utilized to promote relaxation, which may support improved sleep quality in individuals experiencing minor sleep disturbances. Additionally, the practice is sometimes sought out to provide relief in cases of general discomfort or mild nausea.

It is important to understand that this practice is intended to complement existing treatments and is not a substitute for conventional medical care.

Eligibility and Restrictions for Use

Who Can and Cannot Use Aroma?

The population eligibility for Aroma (Ketoconazole Medicated Shampoo) is strictly defined by regulatory documents, focusing on patient age, known allergies, and the integrity of the application site.


Absolute Non-Eligibility (Contraindications)

Classification Population/Condition
Contraindicated Individuals with known hypersensitivity or allergic reaction to Ketoconazole or any component of the formulation.
Site Restriction Use is prohibited on a broken or acutely inflamed scalp.

Age and Physiological Eligibility

Population Group Regulatory Status
Adults & Adolescents (Ages 12) Approved for use under standard labeled conditions.
Children (Under 12 Years) Safety and effectiveness have not been established; use is not recommended.
Pregnancy (Category C) Use is conditional, permitted only if the potential benefit justifies the potential risk to the fetus.
Lactation Caution should be exercised when administered to a nursing woman.

This information is based solely on official government-approved labeling and establishes who is eligible to use the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The interaction profile for Ketoconazole Medicated Shampoo is uniquely constrained by its topical administration, resulting in minimal to non-detectable systemic absorption. Consequently, official regulatory documentation generally excludes the extensive systemic metabolic interactions associated with oral ketoconazole, such as those related to Cytochrome P450 enzymes.

Field Official Regulatory Statement
Systemic Pharmacokinetic Interactions Not considered clinically relevant. Contraindicated combinations with systemic medicines are not listed for the topical formulation.
Medicinal Product Categories Topical Corticosteroids (due to local-to-systemic absorption concern).
Mechanistic Basis Pharmacodynamic interaction based on combined local absorption, leading to a risk of adrenal suppression and rebound effects if managed incorrectly.

Interaction Restrictions and Management

Official labeling defines the primary constraint as a required procedural management when co-administering with potent topical corticosteroids. Regulatory documents mandate a gradual withdrawal schedule for the corticosteroid, typically over several weeks, which serves as a timing-based interaction rule. Abrupt discontinuation of the corticosteroid while initiating the shampoo is prohibited due to the risk of adverse effects. Furthermore, official labeling does not document interactions with food, alcohol, or herbal products for this topical formulation.

Mechanism of Action

How Aroma Works

The physiological action of this mechanism relies on a molecular intervention that causes a functional breakdown of the fungal cell, which terminates proliferation.


Targeted Inhibition of Fungal Enzyme Systems

This mechanism works by specifically inhibiting the enzyme Lanosterol 14alpha-demethylase (CYP51A1), a vital enzyme within the fungal cytochrome P450 system. By binding to the enzyme's heme iron, the drug blocks the conversion of lanosterol into ergosterol, which is an essential fungal lipid.

Disruption of Cell Membrane Integrity

The lack of essential ergosterol and the accumulation of toxic precursor sterols lead to a fundamental compromise of the fungal cell membrane's structure. This mechanism increases membrane permeability and fluidity, preventing the cell from maintaining its internal environment and ultimately resulting in the loss of cellular viability and termination of superficial proliferation.

Dosage and Administration Information

How to Use Aroma (Ketoconazole Medicated Shampoo)

This section describes the high-level administration principles for Aroma (Ketoconazole Medicated Shampoo 2%).


Administration Protocol

The medicine is designed exclusively for topical application (cutaneous administration) to the scalp and/or skin, not for internal use. The standard dosage is the volume sufficient to fully cover the affected area and a margin surrounding it.

Feature Official Guideline
Route Topical Application
Form Medicated Shampoo (Topical Suspension 2%)
Frequency (Treatment) Twice weekly (e.g., every 3 or 4 days)
Frequency (Maintenance) Intermittent use, typically once every 1 to 2 weeks

Procedural and Timing Instructions

Application follows a specific procedure. The shampoo must be applied to damp skin or hair and subsequently lathered. It is crucial that the lathered product remains in contact with the treated area for a specific duration of 3 to 5 minutes to ensure proper delivery of the active component before being rinsed off thoroughly with water.

Special Conditions: The product is strictly for external use. Contact with the eyes or other mucous membranes must be avoided; if contact occurs, the area should be rinsed with water.

Course Duration: The typical treatment duration for the initial regimen is 2 to 4 weeks, after which usage transitions to a long-term intermittent schedule as needed. The use of the shampoo is generally intended for adults and adolescents, with safety and effectiveness not established for children younger than 12 years.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aroma (Ketoconazole Shampoo)


Evidence for Use in Seborrheic Dermatitis (Dandruff)

Research has primarily examined this product through short-term, double-blind RCTs. These studies were used in research exploring how symptoms change over time in adults diagnosed with seborrheic dermatitis. Researchers monitored outcomes related to inflammatory or irritative states, such as scaling score and erythema (redness), along with outcomes related to physical discomfort like pruritus (itching) severity. These studies observed responses over defined time intervals, typically lasting around four weeks.

The findings describe patterns observed in the studies related to scaling and pruritus scores. Research describes how investigator global assessment ratings were applied, which provides insight into short-term changes in the overall appearance of the scalp in the observed populations. Studies monitored microbiological findings related to Malassezia yeast counts during the study period. Data show patterns related to outcomes when the product was evaluated in comparative trials against a placebo control.

Evidence for Use in Tinea Versicolor

Research examined the topical suspension through randomized, double-blind trials focusing on this skin condition, which is associated with acute or disruptive episodes. Studies monitored outcomes related to systemic or functional imbalance, specifically mycological clearance and complete clinical resolution of skin symptoms (scaling, itching, and discoloration) were monitored. The populations included adults with this condition, with research exploring short-term symptom changes based on specific study protocols.

Research highlights changes measured during the study period using mycological assessment results. Studies report how symptoms evolved in the observed populations, detailing changes in skin appearance and associated patient-reported outcomes describing perceived discomfort over a short follow-up period. Data show patterns related to recurrence rates within the initial few months following the brief administration course.


Key Areas of Uncertainty and Research Gaps

Long-term effects are not fully established regarding the durability of study outcomes following the cessation of initial treatment. Evidence is limited and findings were mixed for the adjunctive use in androgenetic alopecia. Comparative evidence is lacking in certain scenarios, and subgroup findings are uncertain when evaluated alongside other active ingredients across diverse populations. Data for certain groups, such as pediatric patients (children younger than 12 years of age), remain insufficient to confirm safety and outcomes. Study results reflect the specific conditions under which they were conducted, and the results apply only to the populations studied.

Frequently Asked Questions (FAQ)

Common questions about Aroma (FAQ)

Q: Is Aroma the same type of medicine as [similar drug name]? What's the main difference?

Official information describes Aroma as a synthetic Azole antifungal medicine. This means it belongs to a specific class of drugs that combat fungi by disrupting the synthesis of ergosterol, a crucial structural lipid in the fungal cell membrane. The active ingredient's mechanism is defined by this specific targeting of the fungal cell structure.

Q: Is Aroma appropriate for use by elderly patients?

Official product information, such as that issued by regulatory bodies, specifies that Ketoconazole medicated shampoo is indicated for use in Adults including the elderly, as well as adolescents. No specific dosage adjustments are typically noted for the elderly population when using this topical formulation.

Q: Can I take Aroma if I have certain pre-existing conditions, like kidney issues?

Because this is a topical product with minimal systemic absorption, the medicine is generally not detected in the bloodstream in clinically significant amounts. Therefore, official regulatory labeling usually does not list dosage adjustments or specific contraindications related to conditions of systemic organ function, such as kidney or liver issues.

Q: What is the official classification of Aroma (e.g., controlled substance, prescription only)?

The regulatory classification of the product can vary depending on its concentration. Lower concentrations of the active ingredient are typically available as over-the-counter (OTC) medicines, while the higher strengths (e.g., 2%) are often classified as prescription-only. It is generally not associated with risks of physical dependence or abuse.

Q: Why is it described that Aroma is not suitable for people with a history of [specific condition]?

The absolute restriction, or contraindication, for using this product is for individuals with a known hypersensitivity to Ketoconazole or any other component in the shampoo formulation. This means the medicine is not suitable for anyone who has previously had a proven allergic reaction to its ingredients.

Q: What does 'contraindication' mean in the context of Aroma?

A contraindication is a term used by medical bodies to describe any symptom or medical condition that is a clear reason for a person to not receive a particular treatment. Official documents use this term to highlight specific situations where the medicine should not be used because it carries an unacceptable risk.

Q: What is the 'Maximum Recommended Dose' described in the official documents for Aroma?

Official labeling defines the quantity needed as the volume sufficient to fully cover the affected area and the surrounding margin. The primary limits are placed on the strict frequency (e.g., twice weekly) and the maximum duration the lather should remain in contact with the skin (e.g., 3 to 5 minutes).

Q: What are the official guidelines regarding stopping Aroma treatment?

Official instructions define a clear treatment duration (e.g., 2 to 4 weeks), after which use is intended to transition to a long-term intermittent schedule as needed to control symptoms. In cases where the shampoo is co-administered with a potent topical corticosteroid, regulatory documents mandate a gradual withdrawal schedule for the corticosteroid.

Q: What happens to Aroma in the body (pharmacokinetics) once it's taken?

Studies indicate that when applied to the skin and scalp, Ketoconazole is generally not detected in the plasma (blood) following chronic use. The effect is intended to remain localized at the application site with minimal circulation throughout the body.

Q: How long after taking the last dose of Aroma does it typically stay in the body?

Due to its minimal systemic absorption, regulatory data indicates the active ingredient is generally not detected in the plasma after chronic use. As the product is intended to act locally, the systemic clearance time (how long it stays in the body) is not considered clinically relevant.

Q: What is the main safety concern or warning highlighted in the US label for Aroma?

The safety profile highlights the potential for severe hypersensitivity reactions, which include rare reports of anaphylaxis and angioedema (swelling beneath the skin). These serious allergic responses are noted as serious events in the safety profile.

Q: How quickly does the effect of Aroma typically start?

While the official label does not provide a specific onset time, clinical research indicates that relief from symptoms like itching may be noticed within a few uses of the shampoo, while full control of the underlying condition may require the full 2 to 4 weeks of the initial treatment regimen.

Q: What is the expected duration of the effects of Aroma?

The duration of the therapeutic effect is related to the management of the underlying condition. Regulatory documents describe that the treatment is followed by an ongoing, long-term intermittent schedule of use as needed to help prevent the symptoms from returning.

Q: Does Aroma affect your ability to drive or operate machinery?

Due to its minimal systemic absorption, the medicine is not expected to cause central nervous system (CNS) effects that would typically impair the ability to drive or operate machinery. Official labeling often does not include specific warnings for these activities because the drug acts locally.

Q: Is Aroma available in different strengths?

Yes, the active ingredient Ketoconazole is commonly available in two strengths. A lower concentration (e.g., 1%) is often sold over-the-counter, and a higher concentration (e.g., 2%) typically requires a prescription.

Q: Has Aroma been approved in countries outside the US, like in Europe or Canada?

Yes, products containing Ketoconazole shampoo are approved and regulated by government bodies outside the US, including the European Medicines Agency (EMA), the UK's MHRA, and Health Canada. This means it is available for use in many countries globally.

Q: Does Aroma have a generic version available?

Yes, regulatory listings and official drug information indicate that generic versions of medications containing the active ingredient Ketoconazole are available in addition to branded products.

Q: What is the risk of dependence or abuse associated with Aroma?

Official classifications indicate that Ketoconazole is not listed as a controlled substance by regulatory agencies. Therefore, it is generally not associated with risks of physical dependence or abuse.

Q: What is the difference between an 'adverse event' and a 'side effect' in the context of Aroma?

Safety summaries typically describe a side effect as an expected or known reaction to the drug that is monitored in clinical trials. In contrast, an adverse event refers to any undesirable experience that occurs during treatment, regardless of whether it is confirmed to be caused by the medicine.

How should Aroma be stored and disposed of?

How to Store and Dispose of AROMA (Ketoconazole Medicated Shampoo)

Storage Requirements

AROMA topical suspension must be stored at controlled room temperature, maintaining a required range between 20 C and 25 C. The product must be protected from light, and it is strictly prohibited to freeze the container. To ensure stability and prevent contamination, the medication should be kept in its original container with the cap tightly closed.

Child Safety and Disposal

The product is required to be stored out of the sight and reach of children. When discarding unused or expired medication, it must not be flushed down the toilet or poured into any drain. The recommended disposal method is to utilize a local medicine take-back program. If a program is unavailable, follow guidelines to mix the product with an undesirable substance before sealing and placing in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aroma found in:

A-Z Index: